Page last updated: 2024-09-04

abiraterone and metribolone

abiraterone has been researched along with metribolone in 2 studies

Compound Research Comparison

Studies (abiraterone)	Trials (abiraterone)	Recent Studies (post-2010) (abiraterone)	Studies (metribolone)	Trials (metribolone)	Recent Studies (post-2010) (metribolone)
942	97	854	744	0	92

Protein Interaction Comparison

Protein	Taxonomy	metribolone (IC50)
Sex hormone-binding globulin	Rattus norvegicus (Norway rat)	0.0037
Androgen receptor	Homo sapiens (human)	0.004
Androgen receptor	Rattus norvegicus (Norway rat)	0.002

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, C; Chen, Y; Li, X; Yan, G; Yu, J; Zhang, L; Zhou, F; Zhou, P	1
Arlt, W; Attard, G; Carreira, S; de Bono, JS; Goodall, J; Hay, CW; Lim, AC; McEwan, IJ; Nowakowska, K; Pezaro, C; Richards, J; Taylor, AE; Wingate, A	1

Other Studies

2 other study(ies) available for abiraterone and metribolone

Article	Year
Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer. European journal of medicinal chemistry, 2019, Jun-01, Volume: 171 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Molecular Structure; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Structure-Activity Relationship; Tumor Cells, Cultured	2019
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer research, 2012, May-01, Volume: 72, Issue:9 Topics: Androgen Receptor Antagonists; Androgens; Androstenes; Androstenols; Anilides; Benzamides; Binding, Competitive; Cell Line, Tumor; Drug Interactions; Eplerenone; Humans; Male; Metribolone; Nitriles; Phenylthiohydantoin; Prednisolone; Prostatic Neoplasms; Receptors, Androgen; Spironolactone; Tosyl Compounds	2012

Article

Year

Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.

European journal of medicinal chemistry, 2019, Jun-01, Volume: 171

Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Molecular Structure; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Structure-Activity Relationship; Tumor Cells, Cultured

2019

Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.

Cancer research, 2012, May-01, Volume: 72, Issue:9

Topics: Androgen Receptor Antagonists; Androgens; Androstenes; Androstenols; Anilides; Benzamides; Binding, Competitive; Cell Line, Tumor; Drug Interactions; Eplerenone; Humans; Male; Metribolone; Nitriles; Phenylthiohydantoin; Prednisolone; Prostatic Neoplasms; Receptors, Androgen; Spironolactone; Tosyl Compounds

2012